Clinical Trial Update: Effect of Intraoperative Controlled Release 5-Fluorouracil Therapy on Recurrence in Hepatocellular Carcinoma Patients [NA]

View source ↗

Summary

A clinical trial update evaluating intraoperative controlled-release 5-fluorouracil therapy to reduce recurrence in hepatocellular carcinoma patients; current s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• 5-Fluorouracil (intraoperative controlled release) (5-fluorouracil)

Snippet

Sponsor: Eastern Hepatobiliary Surgery Hospital | Conditions: Hepatocellular Carcinoma, Recurrence | NA | Status: UNKNOWN